Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-acnal-2-cpa-3-pal-5,6-lys-8-ilys-10-ala-gnrh
2. Gnrh, Ac-nal(1)-cpa(2)-pal(3)-lys(5,6)-ilys(8)-ala(10)-
3. Lhrh,-n-acetyl-2-naphthylalanyl(1)-4-chlorophenylalanyl(2)-3-pyridylalanyl(3)-lysyl(5,6)-iodolysyl(8)-alanine(10)-
1. 134457-26-4
2. Azaline A
3. Dtxsid20158714
4. 1-acnal-2-cpa-3-pal-5,6-lys-8-ilys-10-ala-gnrh
5. Gnrh, Ac-nal(1)-cpa(2)-pal(3)-lys(5,6)-ilys(8)-ala(10)-
6. (s)-n-((2r,4s,7r)-7-acetamido-2-amino-4-((n6-(5-amino-1h-1,2,4-triazol-3-yl)-d-lysyl-l-leucyl)(n6-(5-amino-1h-1,2,4-triazol-3-yl)-l-lysyl)carbamoyl)-1-(4-chlorophenyl)-8-(naphthalen-2-yl)-3,6-dioxooctan-4-yl)-n-(((r)-2-amino-3-(pyridin-3-yl)propanoyl)-l-seryl)-1-(n6-isopropyl-l-lysyl)pyrrolidine-2-carboxamide
7. D-alaninamide, N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n6-(5-amino-1h-1,2,4-triazol-3-yl)-l-lysyl-n6-(5-amino-1h-a,2,4-triazol-3-yl)-d-lysyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-
8. Lhrh, N-acetyl-2-naphthylalanyl(1)-4-chlorophenylalanyl(2)-3-pyridylalanyl(3)-lysyl(5,6)-iodolysyl(8)-alanine(10)-
9. Lhrh,-n-acetyl-2-naphthylalanyl(1)-4-chlorophenylalanyl(2)-3-pyridylalanyl(3)-lysyl(5,6)-iodolysyl(8)-alanine(10)-
10. N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n6-(5-amino-1h-1,2,4-triazol-3-yl)-l-lysyl-n6-(5-amino-1h-1,2,4-triazol-3-yl)-d-lysyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-d-alaninamide
| Molecular Weight | 1545.2 g/mol |
|---|---|
| Molecular Formula | C74H106ClN23O12 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 16 |
| Hydrogen Bond Acceptor Count | 27 |
| Rotatable Bond Count | 44 |
| Exact Mass | 1543.8079836 g/mol |
| Monoisotopic Mass | 1543.8079836 g/mol |
| Topological Polar Surface Area | 568 Ų |
| Heavy Atom Count | 110 |
| Formal Charge | 0 |
| Complexity | 3010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Azaline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azaline, including repackagers and relabelers. The FDA regulates Azaline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azaline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Azaline supplier is an individual or a company that provides Azaline active pharmaceutical ingredient (API) or Azaline finished formulations upon request. The Azaline suppliers may include Azaline API manufacturers, exporters, distributors and traders.
click here to find a list of Azaline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Azaline DMF (Drug Master File) is a document detailing the whole manufacturing process of Azaline active pharmaceutical ingredient (API) in detail. Different forms of Azaline DMFs exist exist since differing nations have different regulations, such as Azaline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Azaline DMF submitted to regulatory agencies in the US is known as a USDMF. Azaline USDMF includes data on Azaline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Azaline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Azaline suppliers with USDMF on PharmaCompass.
Azaline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azaline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azaline GMP manufacturer or Azaline GMP API supplier for your needs.
A Azaline CoA (Certificate of Analysis) is a formal document that attests to Azaline's compliance with Azaline specifications and serves as a tool for batch-level quality control.
Azaline CoA mostly includes findings from lab analyses of a specific batch. For each Azaline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azaline may be tested according to a variety of international standards, such as European Pharmacopoeia (Azaline EP), Azaline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azaline USP).
LOOKING FOR A SUPPLIER?
